Trailblazer


Title: AIDS 392: TRAILBLAZER, elimination of CCR5 receptors with zinc finger to prevent viral replication, in participants living with HIV Purpose: The main purpose of this study is to test a new type of strategy to treat HIV: giving people living with HIV genetically modified versions of their own CD4+ […]

AIDS 392: TRAILBLAZER, elimination of CCR5 receptors with zinc finger ...


Trailblazer studies gene-editing HIV treatment at 3 sites Dr. Carl Fichtenbaum at our sister site at the University of Cincinnati talks about #Trailblazer, our HIV treatment study using zinc finger nucleases to perform gene editing on cells to reduce the reservoir of HIV infection. Link: https://www.uc.edu/news/articles/2019/08/n20848753.html

Carl Fichtenbaum’s UofC IDRU takes on gene editing to reduce ...